Casodex Prostate Cancer Monotherapy Survival Is Similar To Castration - U.K.

Prostate cancer treatment with AstraZeneca's Casodex (bicalutamide) as monotherapy does not increase mortality risk compared to castration, U.K. labeling for the anti-androgen indicates. The Medicines Control Agency cleared the indication on June 17.